home All News open_in_new Full Article

Alzheimer's drugs rejected for NHS use in 'painful setback' for dementia patients

Two drugs – donanemab and lecanemab – have been rejected for NHS use because their benefits are "too small" to justify their cost


today 20 h. ago attach_file Events

attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Events


ID: 3698763236
Add Watch Country

arrow_drop_down